This indefinite delivery contract (IDC) with a ceiling value of $48,683,160.88 was awarded by the Defense Logistics Agency Troop Support Medical (DLA Troop Support Medical) to Pfizer Inc. (Pfizer), a global pharmaceutical corporation. The contract, which has an ultimate completion date of August 31, 2030, does not utilize any set-aside designations.
The contract's primary purpose is for Pfizer to manufacture and distribute a broad range of pharmaceutical products to support various government healthcare initiatives. This includes prescription medications, vaccines, and other medical supplies across disciplines such as immunology, oncology, cardiology, endocrinology, and neurology. The task orders and price lists provided detail the delivery of controlled substances like morphine, fentanyl, and midazolam, as well as antibiotics, steroids, and other critical care medications to be supplied to the DLA Troop Support Medical at a facility in New York, NY. This contract demonstrates Pfizer's significant role as a prime vendor providing pharmaceuticals and vaccines to the U.S. federal government through various Indefinite Delivery Vehicles (IDVs), including a $7.31 billion Federal Supply Schedule contract with the Department of Veterans Affairs and a $121.9 million contract with the Centers for Disease Control and Prevention for adult vaccines.
Generated 8/28/24, 10:57 AM